chr19-17200417-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004145.4(MYO9B):​c.4363G>A​(p.Gly1455Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0367 in 1,578,960 control chromosomes in the GnomAD database, including 1,187 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 81 hom., cov: 32)
Exomes 𝑓: 0.038 ( 1106 hom. )

Consequence

MYO9B
NM_004145.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.721

Publications

8 publications found
Variant links:
Genes affected
MYO9B (HGNC:7609): (myosin IXB) This gene encodes a member of the myosin family of actin-based molecular motor heavy chain proteins. The protein represents an unconventional myosin; it should not be confused with the conventional non-muscle myosin-9 (MYH9). The protein has four IQ motifs located in the neck domain that bind calmodulin, which serves as a light chain. The protein complex has a single-headed structure and exhibits processive movement on actin filaments toward the minus-end. The protein also has rho-GTPase activity. Polymorphisms in this gene are associated with celiac disease and ulcerative colitis susceptibility. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018480718).
BP6
Variant 19-17200417-G-A is Benign according to our data. Variant chr19-17200417-G-A is described in ClinVar as Benign. ClinVar VariationId is 403217.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0277 (4216/152304) while in subpopulation NFE AF = 0.0438 (2981/68018). AF 95% confidence interval is 0.0425. There are 81 homozygotes in GnomAd4. There are 1971 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 4216 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO9BNM_004145.4 linkc.4363G>A p.Gly1455Ser missense_variant Exon 25 of 40 ENST00000682292.1 NP_004136.2 Q13459-1B0I1T6Q8WVD2
MYO9BNM_001130065.2 linkc.4363G>A p.Gly1455Ser missense_variant Exon 25 of 40 NP_001123537.1 Q8WVD2Q4LE74

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO9BENST00000682292.1 linkc.4363G>A p.Gly1455Ser missense_variant Exon 25 of 40 NM_004145.4 ENSP00000507803.1 Q13459-1

Frequencies

GnomAD3 genomes
AF:
0.0277
AC:
4217
AN:
152186
Hom.:
81
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00702
Gnomad AMI
AF:
0.0242
Gnomad AMR
AF:
0.0219
Gnomad ASJ
AF:
0.0482
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00662
Gnomad FIN
AF:
0.0299
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0438
Gnomad OTH
AF:
0.0321
GnomAD2 exomes
AF:
0.0297
AC:
5676
AN:
191160
AF XY:
0.0298
show subpopulations
Gnomad AFR exome
AF:
0.00682
Gnomad AMR exome
AF:
0.0197
Gnomad ASJ exome
AF:
0.0447
Gnomad EAS exome
AF:
0.0000732
Gnomad FIN exome
AF:
0.0312
Gnomad NFE exome
AF:
0.0449
Gnomad OTH exome
AF:
0.0341
GnomAD4 exome
AF:
0.0377
AC:
53762
AN:
1426656
Hom.:
1106
Cov.:
31
AF XY:
0.0369
AC XY:
26111
AN XY:
706718
show subpopulations
African (AFR)
AF:
0.00597
AC:
195
AN:
32672
American (AMR)
AF:
0.0202
AC:
768
AN:
38066
Ashkenazi Jewish (ASJ)
AF:
0.0437
AC:
1118
AN:
25596
East Asian (EAS)
AF:
0.0000786
AC:
3
AN:
38168
South Asian (SAS)
AF:
0.00927
AC:
763
AN:
82302
European-Finnish (FIN)
AF:
0.0303
AC:
1552
AN:
51228
Middle Eastern (MID)
AF:
0.0203
AC:
113
AN:
5564
European-Non Finnish (NFE)
AF:
0.0434
AC:
47427
AN:
1093926
Other (OTH)
AF:
0.0308
AC:
1823
AN:
59134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2926
5853
8779
11706
14632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1752
3504
5256
7008
8760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0277
AC:
4216
AN:
152304
Hom.:
81
Cov.:
32
AF XY:
0.0265
AC XY:
1971
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00700
AC:
291
AN:
41578
American (AMR)
AF:
0.0219
AC:
335
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0482
AC:
167
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.00662
AC:
32
AN:
4832
European-Finnish (FIN)
AF:
0.0299
AC:
317
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0438
AC:
2981
AN:
68018
Other (OTH)
AF:
0.0313
AC:
66
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
206
413
619
826
1032
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0376
Hom.:
398
Bravo
AF:
0.0263
TwinsUK
AF:
0.0364
AC:
135
ALSPAC
AF:
0.0389
AC:
150
ESP6500AA
AF:
0.00713
AC:
29
ESP6500EA
AF:
0.0397
AC:
332
ExAC
AF:
0.0244
AC:
2915
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
12
DANN
Benign
0.38
DEOGEN2
Benign
0.014
.;T;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.61
.;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.20
N;.;N;.
PhyloP100
0.72
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.21
.;.;N;.
REVEL
Benign
0.15
Sift
Benign
0.76
.;.;T;.
Sift4G
Benign
0.85
T;T;T;T
Polyphen
0.0
B;.;B;.
Vest4
0.082
MPC
0.32
ClinPred
0.000055
T
GERP RS
-0.36
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117099942; hg19: chr19-17311226; COSMIC: COSV68278934; COSMIC: COSV68278934; API